Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MYC overexpression + BCL2 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

MYC overexpression (18)

BCL2 overexpression (17)

MYC expression (9)

BCL2 expression (9)

BCL2 expression + MYC expression (8)

BCL2 positive (7)

MYC positive (3)

MYC expression + BCL2 expression (2)

MYC underexpression (2)

miR-17-HG overexpression + MYC positive (2)

BCL2 overexpression + MCL1 overexpression (2)

BCL2 underexpression (2)

BCL2 overexpression + MYC overexpression (1)

BTK expression + BCL2 expression + MYC expression (1)

BTK expression + MYC expression (1)

CHEK1 overexpression + MYC overexpression (1)

MYC expression + BCL2 expression + BCL6 expression (1)

MYC expression + MCL1 expression (1)

MYC negative (1)

MYC positive + BCL2 positive (1)

MYC positive + BCL2 positive + BCL6 positive (1)

MYC expression + PAICS expression (1)

OTUD6B expression + MYC expression (1)

miR-17-HG expression + MYC positive (1)

BCL2 overexpression + CCND1 overexpression (1)

BCL2 overexpression + MCL1 expression (1)

BCL2 overexpression + MCL1 underxpression + BCL2L1 underexpression (1)

BCL2 positive + LGALS3 expression (1)

BTK expression + BCL2 expression (1)

CASP3 overexpression + BCL2 negative (1)

CASP3 underexpression + BCL2 positive (1)

CD20 expression + PAX5 expression + BCL2 expression (1)

CD22 underexpression + BCL2 overexpression (1)

BCL2 positive + IGH positive (0)

MYC overexpression (18)

BCL2 overexpression (17)

MYC expression (9)

BCL2 expression (9)

BCL2 expression + MYC expression (8)

BCL2 positive (7)

MYC positive (3)

MYC expression + BCL2 expression (2)

MYC underexpression (2)

miR-17-HG overexpression + MYC positive (2)

BCL2 overexpression + MCL1 overexpression (2)

BCL2 underexpression (2)

BCL2 overexpression + MYC overexpression (1)

BTK expression + BCL2 expression + MYC expression (1)

BTK expression + MYC expression (1)

CHEK1 overexpression + MYC overexpression (1)

MYC expression + BCL2 expression + BCL6 expression (1)

MYC expression + MCL1 expression (1)

MYC negative (1)

MYC positive + BCL2 positive (1)

MYC positive + BCL2 positive + BCL6 positive (1)

MYC expression + PAICS expression (1)

OTUD6B expression + MYC expression (1)

miR-17-HG expression + MYC positive (1)

BCL2 overexpression + CCND1 overexpression (1)

BCL2 overexpression + MCL1 expression (1)

BCL2 overexpression + MCL1 underxpression + BCL2L1 underexpression (1)

BCL2 positive + LGALS3 expression (1)

BTK expression + BCL2 expression (1)

CASP3 overexpression + BCL2 negative (1)

CASP3 underexpression + BCL2 positive (1)

CD20 expression + PAX5 expression + BCL2 expression (1)

CD22 underexpression + BCL2 overexpression (1)

BCL2 positive + IGH positive (0)

›

MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	ibrutinib Sensitive: B - Late Trials ibrutinib Sensitive : B	ibrutinib Sensitive: B - Late Trials ibrutinib Sensitive : B
MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	axicabtagene ciloleucel Sensitive: C3 – Early Trials axicabtagene ciloleucel Sensitive : C3	axicabtagene ciloleucel Sensitive: C3 – Early Trials axicabtagene ciloleucel Sensitive : C3
MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	azacitidine oral Sensitive: C3 – Early Trials azacitidine oral Sensitive : C3	azacitidine oral Sensitive: C3 – Early Trials azacitidine oral Sensitive : C3
MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	doxorubicin hydrochloride + chidamide Sensitive: D – Preclinical doxorubicin hydrochloride + chidamide Sensitive : D	doxorubicin hydrochloride + chidamide Sensitive: D – Preclinical doxorubicin hydrochloride + chidamide Sensitive : D
MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	CG-806 Sensitive: D – Preclinical CG-806 Sensitive : D	CG-806 Sensitive: D – Preclinical CG-806 Sensitive : D
MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	MYC overexpression + BCL2 overexpression	Diffuse Large B Cell Lymphoma	venetoclax + CG-806 Sensitive: D – Preclinical venetoclax + CG-806 Sensitive : D	venetoclax + CG-806 Sensitive: D – Preclinical venetoclax + CG-806 Sensitive : D